129 related articles for article (PubMed ID: 38346460)
1. Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review.
Jelicic J; Larsen TS; Andjelic B; Juul-Jensen K; Bukumiric Z
Crit Rev Oncol Hematol; 2024 Apr; 196():104293. PubMed ID: 38346460
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
[TBL] [Abstract][Full Text] [Related]
3. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.
Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
Technol Cancer Res Treat; 2023; 22():15330338231180785. PubMed ID: 37551117
[No Abstract] [Full Text] [Related]
4. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma.
Wan M; Zhang W; Huang H; Fang X; Chen Y; Tian Y; Yao Y; Weng H; Chen Z; Yu L; Tian Y; Huang H; Li X; Hong H; Lin T
Clin Exp Med; 2024 Mar; 24(1):64. PubMed ID: 38554186
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and Clinical Significance of Prognostic Nomogram Model for Diffuse Large B-Cell Lymphoma Based on Immunohistochemistry Markers and International Prognostic Index Scores].
Xu YW; Zhou YL; Kong FC; Chen ZW; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):753-761. PubMed ID: 37356936
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China.
Li X; Xu Q; Gao C; Yang Z; Li J; Sun A; Wang Y; Lei H
Ann Hematol; 2023 Dec; 102(12):3465-3475. PubMed ID: 37615680
[TBL] [Abstract][Full Text] [Related]
8. Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database.
Liu Y; Han H; Wei H; Wang X; Luan Z; Jiang K
Recent Pat Anticancer Drug Discov; 2024; 19(3):373-382. PubMed ID: 37464821
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a [
Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a survival nomogram in patients with primary testicular diffuse large B-cell lymphoma.
Zhi Y; Bao S; Mao J; Chai G; Liu C; Zhu J
J Int Med Res; 2023 Sep; 51(9):3000605231197052. PubMed ID: 37676929
[TBL] [Abstract][Full Text] [Related]
13. Benefits of Dynamic Nomogram Models for Elderly Diffuse Large B-Cell Lymphoma Patients' Early Death Prediction and Clinical Application.
Zhang L; Jing H; Tang S; Wang J; Yang P
Mediators Inflamm; 2023; 2023():7874239. PubMed ID: 37096156
[TBL] [Abstract][Full Text] [Related]
14. A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients.
Jiang S; Qin Y; Liu P; Yang J; Yang S; He X; Zhou S; Gui L; Zhang C; Zhou L; Sun Y; Shi Y
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e11-e16. PubMed ID: 31264371
[TBL] [Abstract][Full Text] [Related]
15. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract][Full Text] [Related]
16. Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic Review.
Jelicic J; Larsen TS; Frederiksen H; Andjelic B; Maksimovic M; Bukumiric Z
Clin Epidemiol; 2020; 12():537-555. PubMed ID: 32581596
[TBL] [Abstract][Full Text] [Related]
17. Identification of an individualized RNA binding protein-based prognostic signature for diffuse large B-cell lymphoma.
Xie Y; Luo X; He H; Pan T; He Y
Cancer Med; 2021 Apr; 10(8):2703-2713. PubMed ID: 33749163
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value for long-term survival in diffuse large B-cell lymphoma.
Gao Q; Li Z; Meng L; Ma J; Xi Y; Wang T
Aging (Albany NY); 2020 Nov; 12(22):23275-23295. PubMed ID: 33221755
[TBL] [Abstract][Full Text] [Related]
19. A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma.
Guan M; Zhao H; Zhang Q; Li L; Wang X; Tang B
Expert Rev Mol Diagn; 2024 May; 24(5):439-457. PubMed ID: 38709202
[TBL] [Abstract][Full Text] [Related]
20. Nomogram based on the systemic immune-inflammation index for predicting the prognosis of diffuse large B-cell lymphoma.
Wu J; Zhu H; Zhang Q; Sun Y; He X; Liao J; Liu Y; Huang L
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e138-e148. PubMed ID: 35754170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
